These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27108800)

  • 1. Multi-technique hybrid imaging in PET/CT and PET/MR: what does the future hold?
    de Galiza Barbosa F; Delso G; Ter Voert EE; Huellner MW; Herrmann K; Veit-Haibach P
    Clin Radiol; 2016 Jul; 71(7):660-72. PubMed ID: 27108800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current technological advances in magnetic resonance with critical impact for clinical diagnosis and therapy.
    Runge VM
    Invest Radiol; 2013 Dec; 48(12):869-77. PubMed ID: 24126386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of PET/MRI in oncology.
    Sotoudeh H; Sharma A; Fowler KJ; McConathy J; Dehdashti F
    J Magn Reson Imaging; 2016 Aug; 44(2):265-76. PubMed ID: 27007987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Techniques, benefits, and challenges of PET-MR.
    Ocampo T; Knight K; Dunleavy R; Shah SN
    Radiol Technol; 2015; 86(4):393-412; quiz 413-6. PubMed ID: 25835405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body simultaneous positron emission tomography (PET)-MR: optimization and adaptation of MRI sequences.
    Fowler KJ; McConathy J; Narra VR
    J Magn Reson Imaging; 2014 Feb; 39(2):259-68. PubMed ID: 24436150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous reconstruction of activity and attenuation for PET/MR.
    Salomon A; Goedicke A; Schweizer B; Aach T; Schulz V
    IEEE Trans Med Imaging; 2011 Mar; 30(3):804-13. PubMed ID: 21118768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial experience of MR/PET in a clinical cancer center.
    Partovi S; Robbin MR; Steinbach OC; Kohan A; Rubbert C; Vercher-Conejero JL; Kolthammer JA; Faulhaber P; Paspulati RM; Ros PR
    J Magn Reson Imaging; 2014 Apr; 39(4):768-80. PubMed ID: 24006287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular PET-CT imaging: a new frontier?
    Adamson PD; Williams MC; Newby DE
    Clin Radiol; 2016 Jul; 71(7):647-59. PubMed ID: 26951964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET/MRI: challenges, solutions and perspectives.
    Herzog H
    Z Med Phys; 2012 Dec; 22(4):281-98. PubMed ID: 22925652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
    Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
    J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motion correction using anatomical information in PET/CT and PET/MR hybrid imaging.
    Fayad H; Lamare F; Merlin T; Visvikis D
    Q J Nucl Med Mol Imaging; 2016 Mar; 60(1):12-24. PubMed ID: 26576736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simulation of a MR-PET protocol for staging of head-and-neck cancer including Dixon MR for attenuation correction.
    Eiber M; Souvatzoglou M; Pickhard A; Loeffelbein DJ; Knopf A; Holzapfel K; Martinez-Möller A; Nekolla SG; Scherer EQ; Schwaiger M; Rummeny EJ; Beer AJ
    Eur J Radiol; 2012 Oct; 81(10):2658-65. PubMed ID: 22078793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
    Chavdarova LI; Tzonevska AD; Piperkova EN
    Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there an additive value of 18 F-FDG PET-CT to CT/MRI for detecting nodal metastasis in oropharyngeal squamous cell carcinoma patients with palpably negative neck?
    Sohn B; Koh YW; Kang WJ; Lee JH; Shin NY; Kim J
    Acta Radiol; 2016 Nov; 57(11):1352-1359. PubMed ID: 26013025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Segmentation-based attenuation correction in positron emission tomography/magnetic resonance: erroneous tissue identification and its impact on positron emission tomography interpretation.
    Brendle C; Schmidt H; Oergel A; Bezrukov I; Mueller M; Schraml C; Pfannenberg C; la Fougère C; Nikolaou K; Schwenzer N
    Invest Radiol; 2015 May; 50(5):339-46. PubMed ID: 25585210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the CT component of PET-CT to improve PET-MR registration: demonstration in soft-tissue sarcoma.
    Somer EJ; Benatar NA; O'Doherty MJ; Smith MA; Marsden PK
    Phys Med Biol; 2007 Dec; 52(23):6991-7006. PubMed ID: 18029989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/CT: panacea, redundancy, or something in between?
    Vogel WV; Oyen WJ; Barentsz JO; Kaanders JH; Corstens FH
    J Nucl Med; 2004 Jan; 45 Suppl 1():15S-24S. PubMed ID: 14736832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET/MR imaging: current and future applications for cardiovascular disease.
    Naeger DM; Behr SC
    Magn Reson Imaging Clin N Am; 2015 Feb; 23(1):95-103. PubMed ID: 25476678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.